1. |
张冬林, 刘东, 方淑贤, 等. 2007~2009年武汉地区血浆代用品应用分析析[J]. 医药导报, 2010, 29(12):1656-1658.
|
2. |
Laxenaire MC. Epidemiologie des reactions anaphylactoidesper-anesthesiques:quatriemeenquetemulticentrique (juillet 1994-decembre 1996)[J]. Ann FrAnesthReanim, 1999, 18(7):796-809.
|
3. |
Fasting S, Gisvold SE. Serious intraoperative problems:a five-year review of 83844 anesthetics[J]. Can J Anaesth, 2002, 49(6):545-553.
|
4. |
Laxenaire MC, Mertes PM, Benabes B, et al. Anaphylaxis during anaesthesia:results of a two-year survey in France[J]. Br JAnaesth, 2001, 87(4):549-558.
|
5. |
Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes:incidence, risk factors, and mechanisms-a French multicenter prospective study[J]. Ann FrAnesthReanim, 1994, 13(3):301-310.
|
6. |
Mishler JM. The structure and chemistry of hydroxyethyl starch. Pharmacology of hydroxyethylstarch[M]. Oxford:Oxford University Press, 1982:1-30.
|
7. |
Kraft D, Sirtl C, Laubenthal H, et al. No evidence for the existence of preformed antibodies against hydroxyethyl starch in man[J]. Eur Surg Res, 1992, 24(3):138-142.
|
8. |
Dieterich HJ, Kraft D, Sirtl C, et al. Hydroxyethyl starch antibodies in humans:incidence and clinical relevance[J]. Anesth Analg, 1998, 86(5):1123-1126.
|
9. |
Kroigaard M, Garvey LH, Gillberg L,et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia[J]. Acta Anaesthesiol Scand, 2007, 51(6):655-670.
|
10. |
刘小颖, 吴新民, 薛张纲, 等. 国产与进口6%羟乙基130/0.4注射液容量治疗疗效和安全性的对比研究[J]. 临床麻醉学杂志, 2009, 25(5):406-408.
|
11. |
姚元章, 孙士锦, 王韬等. 国产与进口羟乙基淀粉溶液的临床疗效与不良反应比较[J]. 中国临床药学杂志, 2006, 15(4):209-212.
|
12. |
孙桂斌, 杭太俊. 羟乙基淀粉130/0.4氯化钠注射液相对分子质量及分布的测定[J]. 药物分析杂志, 2009, 29(10):1643-1645.
|
13. |
Lieberman P. Anaphylactic reactions during surgical and medical procedures[J]. J Allergy ClinImmunol. 2002, 110(2 Suppl):S64-69.
|
14. |
张秀华, 黄宇光. 围术期羟乙基淀粉容量治疗的安全性[J]. 临床麻醉学杂志, 2006, 22(12):937-938.
|